Recent Posts

Stocks in Frontline Trades’ Choice: Arrowhead Pharmaceuticals (NASDAQ:ARWR), Mastercard Incorporated (NYSE:MA)

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) [Trend Analysis] luring active investment momentum, shares a decrease -67.20% to $1.44. Law Offices of Howard G. Smith released that a class action court case has been filed on behalf of investors who purchased Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) securities among May 11, 2015 and November 8, 2016, …

Read More »